REG - Kingspan Group PLC Kingspan Group - KGP - Application for Additional Listing of Shares

KingspanAnnouncement

05/01/2024 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240105:nRSE8351Ya&default-theme=true

RNS Number : 8351Y  Kingspan Group PLC  05 January 2024

KINGSPAN GROUP PLC

 

Application for Additional Listing of Shares

 

5 January 2024

 

Kingspan Group plc, announces that 1,004,960 new Ordinary Shares of €0.13
each in the Company ('New Ordinary Shares') have been allotted and issued by
the Company to Schramek GmbH.  The allotment is made pursuant to a share
subscription agreement and in accordance with the completion of the sale and
purchase agreement between Kingspan Group plc and Schramek GmbH of 51% of the
shares in Steico SE, as announced earlier today.

 

Application has been made to Euronext Dublin for the New Ordinary Shares to be
admitted to the Official List and to trading on the main market for listed
securities of Euronext Dublin.  Admission is expected to take place on 8
January 2024. The New Ordinary Shares rank pari passu with the existing
Ordinary Shares in the Company.

 

Following the above allotment, the Company's issued share capital will
comprise 184,596,642 Ordinary Shares of €0.13 each.  The Company holds
1,516,936 Ordinary Shares in treasury.   Therefore, the total number of
voting rights in the Company is 183,079,706.

 

The above figure 183,079,706 may be used by shareholders as the denominator
for the calculations by which they will determine if they are required to
notify their interest, or a change to their interest, in Kingspan Group plc
under the Disclosure and Transparency Rules.

 

For further information please contact:

 

Lorcan Dowd

Company Secretary

+ 353 (0)42 9698000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ALSQKPBDQBKDBDK